The Feinstein Institutes, founded in 1999, serves as the research arm of Northwell Health, the largest healthcare provider in New York State. Operating across six research institutes, they aim at 'Producing knowledge to cure disease'. The Institutes employ over 5,000 researchers and staff, focusing on innovative treatments for complex diseases including lupus, arthritis, sepsis, cancer, psychiatric disorders, and Alzheimer’s disease.
Pioneering the field of bioelectronic medicine, The Feinstein Institutes specialize in leveraging electronic medical devices to trigger the body’s own healing mechanisms, underscoring their position as a leader in medical innovation.
Most recently, they secured a $6.10M grant investment on 03 April 2024 from the National Institutes of Health, evidencing strong support and recognition from prominent funding bodies in the biomedical research domain.